fashion -WSS

fashion

author：focus 2025-09-03 12:10:29 - browse：1

parts of a dna helix fades while a segment stays solid — Adobe

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom.

Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age. Those conditions include immune diseases, cancers, neurodegenerative illnesses, and cardiometabolic disorders, such as heart attacks, strokes and diabetes.

With an initial of $50 million from the venture firm Flagship Pioneering, Quotient will be located in Cambridge, Mass., and Cambridge, England. Most of the academic co-founders work in the UK city. Quotient is the first Flagship-backed biotech that will be based in both countries.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

WSS

Rock icon Freddie Mercury pre

A new nitrogen execution bill also undermines medical licensing

The Harvard botanist who searched for psychedelics in the Amazon

The Harvard botanist who searched for psychedelics in the Amazon

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Calls for Trump's election interference trial to be televised part of long debate

explore

fashion

hotspot

At least 13 dead in Texas as scorching temps continue

STAT readers on older presidents, polypills, Medicare, and more

The high cost of giving birth even with insurance

R1 RCM gets $5.8 billion buyout offer from private equity firm

Hollywood unions extend contract negotiations for actors

R1 RCM gets $5.8 billion buyout offer from private equity firm

Anesthesiologist group: stop taking Ozempic before surgery

Antivenom research: Lessons from HIV applied in search for universal antidote

Heart attack and stroke risk calculators need revising

Why palliative psychiatry is worth discussing

explore

Dario to buy mental health app maker Twill in cash and stock deal

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

With competition flaring, obesity drug hits goal in liver disease study

The Harvard botanist who searched for psychedelics in the Amazon

NIH study of ME/CFS points to clear biological hallmarks

STAT readers on older presidents, polypills, Medicare, and more

hotspot

knowledge

leisure time

hotspot